President Donald Trump is considering a significant change in federal marijuana policy, potentially easing restrictions on the substance. According to a recent report from The Wall Street Journal, Trump might reclassify marijuana from a Schedule I drug—alongside heroin and LSD—to a Schedule III drug. This shift would suggest that marijuana has a “moderate to low potential for physical and psychological dependence,” according to the Drug Enforcement Administration.
The President’s interest in this change coincides with financial support from the marijuana industry to his political entities. During a fundraiser at his golf club in New Jersey, where tickets were priced at a staggering $1 million each, Trump indicated that he is weighing how to treat marijuana under federal law. At the event, he expressed a clear openness to reclassification, highlighting conversations with industry leaders.
Among the attendees was Kim Rivers, the CEO of Trulieve, who advocated for increased medical marijuana research. Trump’s willingness to consider such changes adds a notable layer to his ongoing negotiations with marijuana producers. This political connection has become increasingly evident, especially after a failed ballot measure in Florida that sought to enshrine legalized marijuana into the state constitution.
Sources cited by The Wall Street Journal suggest that Trump’s commitment to the marijuana issue may further align with his broader political strategy. An adviser noted that he is keen on “80-20 cultural issues,” referring to matters where there is significant public support. Abigail Jackson, a spokeswoman for the White House, emphasized that “all policy and legal requirements and implications are being considered,” reiterating that the President’s primary focus is the best interest of the American people.
The implications of this potential reclassification are profound. If marijuana moves to Schedule III, it would pave the way for expanded medical research funding and access to treatments for various conditions, from chronic pain to anxiety disorders. As the landscape around marijuana continues to evolve, Trump’s decisions could significantly influence its future in American society.
"*" indicates required fields
